Monoamine Oxidase Inhibitors
Also known as: MAOIs, MAOI antidepressants, monoamine oxidase inhibitors
Overview
Monoamine oxidase inhibitors (MAOIs) are a class of prescription medications primarily used in the treatment of depression, with additional roles in certain anxiety disorders and neurological conditions depending on the specific drug. They work by inhibiting the enzyme monoamine oxidase, which normally breaks down neurotransmitters such as serotonin, norepinephrine, and dopamine. By slowing this breakdown, MAOIs can increase the availability of these signaling molecules in the brain. Although they were among the earliest antidepressants developed, they are now used less commonly than newer agents because of their significant food and drug interaction potential.
MAOIs remain clinically important because some patients with treatment-resistant depression, atypical depression, or particular symptom patterns may respond when other antidepressant classes have not helped. Commonly discussed MAOIs include phenelzine, tranylcypromine, isocarboxazid, and the transdermal form of selegiline. Their reputation is closely tied to the need for caution around tyramine-containing foods and interactions with other medications and supplements that affect serotonin or catecholamines.
This topic is frequently explored not only from a psychiatric medication standpoint, but also in the context of dietary restrictions, herb-drug interactions, and interest in complementary approaches to mood support. That broader discussion is important because MAOIs can interact with substances sometimes perceived as “natural” or low-risk, including certain herbal products, stimulant compounds, and over-the-counter cold remedies. For this reason, MAOIs are often considered a medication class where integrative care and careful medication review are especially important.
From a public health perspective, MAOIs are not the most commonly prescribed antidepressants today, but they continue to have a meaningful niche in mental health care. Their use highlights an important principle in medicine: older therapies may remain valuable when used thoughtfully, particularly in complex or refractory cases. At the same time, because of the possibility of hypertensive crisis, serotonin toxicity, and other serious adverse interactions, discussions of MAOIs generally emphasize the importance of individualized medical supervision and coordination between conventional and complementary care providers.
Western Medicine Perspective
Western Medicine Perspective
In conventional medicine, MAOIs are understood through neurochemical mechanisms and risk-benefit assessment. The enzyme monoamine oxidase exists in two forms, MAO-A and MAO-B, which help metabolize neurotransmitters and dietary amines. Nonselective MAOIs used for depression inhibit these pathways more broadly, which can improve mood symptoms in some individuals but also raises the risk of interaction with tyramine-rich foods and various medications. When tyramine is not adequately broken down, blood pressure may rise sharply, creating the risk of a hypertensive emergency. Similarly, combining MAOIs with serotonergic agents can lead to serotonin syndrome, a potentially life-threatening condition.
Clinical literature suggests MAOIs may be particularly relevant in treatment-resistant depression, atypical depression, and selected anxiety-related conditions. However, because safer and easier-to-manage antidepressants are often available, most guidelines reserve MAOIs for cases where first-line treatments have not been effective or tolerated. Their use typically involves careful review of current prescriptions, supplements, recent antidepressant exposure, and diet. Washout periods between medications are a major feature of safe prescribing, especially when switching to or from SSRIs, SNRIs, tricyclics, certain pain medications, stimulants, or migraine therapies.
Western medicine also pays close attention to adverse effects and contraindications. Depending on the specific MAOI, side effects may include orthostatic hypotension, insomnia, agitation, dry mouth, sexual dysfunction, edema, and weight changes. Monitoring often includes assessment of blood pressure, mental status, interaction risk, and any signs of headache, palpitations, or neuromuscular symptoms that could indicate a serious reaction. Because even nonprescription products can be relevant, conventional care generally emphasizes that all substances—herbs, supplements, decongestants, cough medicines, and energy products—be disclosed to a qualified healthcare professional before use.
A modern conventional view of MAOIs is therefore nuanced: they are not obsolete, but rather specialized medications with meaningful benefits for selected patients and a relatively high need for education and supervision. Research continues around more selective MAO-related therapies and safer delivery systems, but the currently used MAOIs remain a category where pharmacology, psychiatry, nutrition, and medication safety intersect closely.
Eastern & Traditional Perspective
Eastern and Traditional Medicine Perspective
Traditional medical systems do not describe monoamine oxidase inhibitors in modern biochemical terms, since MAOIs are pharmaceutical agents developed within contemporary medicine. However, systems such as Traditional Chinese Medicine (TCM), Ayurveda, and naturopathic traditions have long approached low mood, emotional stagnation, fatigue, sleep disturbance, and loss of vitality through their own diagnostic frameworks. In TCM, depressive patterns may be interpreted through concepts such as Liver qi stagnation, Heart shen disturbance, Spleen qi deficiency, or combinations involving phlegm, heat, or blood deficiency. In Ayurveda, mood disorders may be discussed in relation to dosha imbalance, impaired mental clarity, nervous system dysregulation, or reduced resilience of mind and body.
These traditions often emphasize that emotional symptoms arise from a broader pattern involving digestion, sleep, stress load, constitution, environment, and social connection. As a result, traditional approaches may include herbal formulas, dietary principles, mind-body practices, breathing exercises, meditation, acupuncture, or lifestyle restructuring. Research into some of these approaches suggests potential benefit for mood support in certain populations, but findings are mixed, interventions vary widely, and the evidence base is generally less standardized than for pharmaceutical antidepressants.
The most important integrative issue with MAOIs is interaction risk. A number of herbs and natural products commonly discussed for mood, energy, or cognition may be problematic when combined with MAOIs. Examples frequently raised in safety discussions include St. John’s wort, 5-HTP, SAMe, certain stimulant-containing products, and some traditional or multi-ingredient formulas whose pharmacology is not fully characterized. Even when a product is traditionally used for emotional balance, “natural” does not necessarily mean compatible with MAOI therapy. This is one reason integrative practitioners often stress full disclosure of all supplements and traditional remedies to the prescribing clinician.
From an eastern or traditional perspective, MAOI use may be seen as one element within a broader picture of restoring emotional and physiological balance. A balanced integrative approach generally respects the role of conventional psychiatric care while recognizing that supportive practices—such as stress reduction, sleep regulation, gentle movement, and individualized traditional assessment—may matter to overall wellbeing. Because of the potentially serious interaction profile of MAOIs, any complementary framework is best considered in coordination with appropriately qualified healthcare professionals.
Evidence & Sources
Supported by multiple clinical trials and systematic reviews
- American Psychiatric Association Practice Guidelines
- National Institute of Mental Health (NIMH)
- National Center for Biotechnology Information (StatPearls)
- U.S. Food and Drug Administration (FDA) prescribing information for MAOIs
- New England Journal of Medicine
- The Lancet Psychiatry
- National Center for Complementary and Integrative Health (NCCIH)
- British Journal of Psychiatry
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.